Amedisys Reports First Quarter 2017 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Amedisys Reports First Quarter 2017 Financial Results

Mizuho Securities Upgrades Amedisys (AMED) to Buy; Pay Up for Strong Management

May 3, 2017 7:30 AM EDT

Mizuho Securities upgraded Amedisys (NASDAQ: AMED) from Neutral to Buy with a price target of $65.00.

Analyst Sheryl Skolnick is positive on management amid Q1 results. "AMED's 1Q17 result demonstrates just that: not only are cost savings real, but the balanced approach to... More